Dramatic shift from Brussels, which had long defended the principle that members must treat one another equally ...

Five months ago, J&J also revealed its plan to spend $2 billion over the next 10 years to operate a 160,000-square-foot ...

Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing agreement with the Trump ...

At Davos 2026, Novartis CEO Vas Narasimhan said regulatory clarity in the US and a rapid reshaping of the company’s supply ...

Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...

AbbVie is now one of 16 big pharma companies to sign MFN deals with the Trump administration and commit to the expansion of ...

With a White House drug pricing deal done and dusted and the threat of tariffs ameliorated, Sanofi is enjoying more clarity from the U.S. government now than the same time last year. But several ...

Throughout 2025, Congress introduced several bills related to the pharmacy benefit management (PBM) industry. As with the 118th Congress in 2024 ...

What the deals have in common is price reductions for Medicaid, MFN prices for new launches, and discounts for self-paying ...

The US has been demonstrating hostility towards international norms since the beginning of 2025. The past year saw the ...

Acadia Pharma’s Catherine Owen Adams has formed a group of small- to mid-cap biotechs to advocate against a ‘peanut butter ...